Si-Bone (Nasdaq:SIBN) this week announced preliminary fourth-quarter results that exceeded expectations on Wall Street. The Santa Clara, California-based orthopedic device company expects worldwide revenue to be in the range of $31.7-$31.9 million for Q4 2022. The sales represent a 26% growth year-over-year. For the full year 2022, Si-Bone anticipates reporting worldwide revenue in the range […]
Si-Bone
Si-Bone wins expanded FDA clearance for iFuse Bedrock Granite implant
Si-Bone (Nasdaq:SIBN) announced today that it received additional FDA clearance for its iFuse Bedrock Granite implant. New indications for the implant include its use with a range of commercially available pedicle screw systems. Santa Clara, California-based Si-Bone received FDA 510(k) clearance for iFuse Bedrock Granite for spinal procedures in May. It designed the implant to […]
Si-Bone wins FDA clearance for expanded iFuse-TORQ implant indication
Si-Bone announced today that the FDA granted clearance for its iFuse-TORQ implant for pelvic fracture fixation. The regulatory nod expands Si-Bone’s iFuse-TORQ’s indication for acute, non-acute and non-traumatic pelvic fractures, including pelvic fragility fractures (fractures related to low-energy traumatic events) and pelvic insufficiency fractures. Santa Clara, California-based Si-Bone said in a news release that the […]
Si-Bone wins FDA clearance for pelvic fixation, fusion tech
Si-Bone announced today that it received FDA 510(k) clearance for its iFuse Bedrock Granite implant system for spinal procedures. Santa Clara, California-based Si-Bone designed the iFuse “Granite” implant to provide sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. According to a news release, FDA clearance follows earlier breakthrough device designation […]
Si-Bone posts mixed bag Q4 results
Si-Bone (NSDQ:SIBN) this week posted fourth-quarter results that beat revenue consensus on Wall Street but miss earnings estimates. The Santa Clara, California-based musculoskeletal treatment device company reported losses of -$14.5 million, or -43¢ per share, on sales of $25.2 million for the three months ended Dec. 31, 2021 for a sales growth of 13.94% compared […]
Laura Francis to move up to CEO spot at Si-Bone
Si-Bone (NSDQ:SIBN) will promote its present CFO and COO Laura Francis into the corner office of the company, which makes the iFuse implant for treating lower back pain. Francis will become CEO once the company finds a new CFO or May 1 — whatever comes first. Present CEO Jeff Dunn will stay with the company as […]
Si-Bone tops estimates with Q4 prelims | Wall Street Beat
Si-Bone (NSDQ:SIBN) said today that it expects to record fourth-quarter sales of $15.4 million to $15.6 million, up 12 – 13% from the same period last year. The company pegged its full-year sales for 2018 between $55.2 million and $55.4 million, up 15% from 2017. Analysts on Wall Street are expecting Si-Bone to post Q4 sales […]
Si-Bone closes $124m IPO
Si-Bone (NSDQ:SIBN) last week closed an initial public offering that brought in much more than anticipated for its iFuse sacroiliac implant. The Santa Clara, Calif.-based company priced the 7.2-million-share flotation at $15 per share, which at $108 million would have topped its initial range of about $90 million to nearly $104 million (which itself would have beaten […]
Si-Bone prices upsized $108m IPO
Si-Bone yesterday priced its initial public offering, which launched today, lifting the total it hopes to bring in from a previous maximum of $103.5 million up to $108 million. In the offering, the Santa Clara, Calif.-based company said it will offer 7.2 million shares at $15 per share. Si-Bone had previously said it expected to offer […]
Si-Bone sets price range for $104m IPO
Si-Bone has set a price range for its upcoming initial public offering, looking to bring in between $89.7 million and $103.5 million, according to an SEC filing posted late last week The Santa Clara, Calif.-based company said that it plans to offer 6.9 million shares at between $13 and $15 per share in the offering, and […]
Si-Bone registers for $98m IPO
Si-Bone yesterday registered for an initial public offering, looking to bring in approximately $97.8 million, according to an SEC filing. The Santa Clara, Calif.-based company said that it plans to list on the Nasdaq Global Market under the ticker symbol “SIBN.” Morgan Stanley and BofA Merrill Lynch are acting as joint book-running managers for the IPO, […]
